Farbe Firma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-01-2025
- Paid Up Capital ₹ 0.10 M
as on 17-01-2025
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 21.00 Cr
as on 17-01-2025
- Revenue 62.98%
(FY 2024)
- Profit -100.56%
(FY 2024)
- Ebitda -50.60%
(FY 2024)
- Net Worth -235.44%
(FY 2024)
- Total Assets -0.97%
(FY 2024)
About Farbe Firma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹21.00 Cr.
Jaysukhbhai Sudani, Maulikkumar Sudani, Jignasu Sudani, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100GJ2021PTC123062
- Company No.
123062
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jun 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Farbe Firma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaysukhbhai Sudani  | Director | 03-Jun-2021 | Current |
| Maulikkumar Sudani | Director | 03-Jun-2021 | Current |
| Jignasu Sudani | Director | 03-Jun-2021 | Current |
| Geetaben Sudani | Director | 03-Jun-2021 | Current |
Financial Performance of Farbe Firma.
Farbe Firma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 62.98% increase. The company also saw a substantial fall in profitability, with a 100.56% decrease in profit. The company's net worth observed a substantial decline by a decrease of 235.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Farbe Firma?
Unlock access to Farbe Firma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Nurasyl Lifesciences Private LimitedActive 5 years 3 monthsMaulikkumar Sudani and Jignasu Sudani are mutual person
Charges (Loans)
₹210.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 21.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Oct 2021 | Hdfc Bank Limited | ₹21.00 Cr | Open |
How Many Employees Work at Farbe Firma?
Farbe Firma has a workforce of 143 employees as of Jan 17, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Farbe Firma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Farbe Firma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
